Meeting Archive:
Immunotherapy: Revolutionizing Cancer Treatment

You can play back the recording of this webinar at the following address:

Meeting Description:

The field of cancer immunotherapy is progressing rapidly as several new agents were FDA approved in 2016. Most exciting are so-called checkpoint inhibitors that “take the brakes off” the immune response, enabling a stronger immune attack against cancer. However, despite their demonstrated benefits, these therapies are effective in only 20-40% of patients. Efficacy may be improved for patients with a baseline immune response prior to treatment, potentially elicited by focused ultrasound. The Foundation has partnered with the Cancer Research Institute (CRI) to help advance the timely development of FUS and immunotherapy combination treatments to improve outcomes and quality of life for cancer patients. 

Date: Tue, Jan 17, 2017
Time: 11:00 AM EST
Duration: 1 hour 30 minutes
Host(s): Focused Ultrasound Foundation
 Presenter Information
Jill O'Donnell-Tormey, PhD
Speaker Photo

Chief Executive Officer and Director of Scientific Affairs,
Cancer Research Institute